These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Clinical, biological, and molecular characteristics of clonal mast cell disorders presenting with systemic mast cell activation symptoms. Alvarez-Twose I; González de Olano D; Sánchez-Muñoz L; Matito A; Esteban-López MI; Vega A; Mateo MB; Alonso Díaz de Durana MD; de la Hoz B; Del Pozo Gil MD; Caballero T; Rosado A; Sánchez Matas I; Teodósio C; Jara-Acevedo M; Mollejo M; García-Montero A; Orfao A; Escribano L J Allergy Clin Immunol; 2010 Jun; 125(6):1269-1278.e2. PubMed ID: 20434205 [TBL] [Abstract][Full Text] [Related]
4. Pediatric Expression of Mast Cell Activation Disorders. Broesby-Olsen S; Carter M; Kjaer HF; Mortz CG; Møller MB; Kristensen TK; Bindslev-Jensen C; Agertoft L Immunol Allergy Clin North Am; 2018 Aug; 38(3):365-377. PubMed ID: 30007457 [TBL] [Abstract][Full Text] [Related]
5. Recent advances in mastocytosis research. Summary of the Vienna Mastocytosis Meeting 1998. Valent P; Escribano L; Parwaresch RM; Schemmel V; Schwartz LB; Sotlar K; Sperr WR; Horny HP Int Arch Allergy Immunol; 1999 Sep; 120(1):1-7. PubMed ID: 10529583 [TBL] [Abstract][Full Text] [Related]
6. The Role of KIT Mutations in Anaphylaxis. Coulson E; Zhou S; Akin C Curr Allergy Asthma Rep; 2019 Apr; 19(6):31. PubMed ID: 31028494 [TBL] [Abstract][Full Text] [Related]
7. Mastocytosis: immunophenotypical features of the transformed mast cells are unique among hematopoietic cells. Horny HP; Sotlar K; Valent P Immunol Allergy Clin North Am; 2014 May; 34(2):315-21. PubMed ID: 24745676 [TBL] [Abstract][Full Text] [Related]
8. The presence of mast cell clonality in patients with unexplained anaphylaxis. Gülen T; Hägglund H; Sander B; Dahlén B; Nilsson G Clin Exp Allergy; 2014 Sep; 44(9):1179-87. PubMed ID: 25039926 [TBL] [Abstract][Full Text] [Related]
9. Anaphylaxis and mast cell disease: what is the risk? Akin C Curr Allergy Asthma Rep; 2010 Jan; 10(1):34-8. PubMed ID: 20425512 [TBL] [Abstract][Full Text] [Related]
10. New Insights into Clonal Mast Cell Disorders Including Mastocytosis. Volertas S; Schuler CF; Akin C Immunol Allergy Clin North Am; 2018 Aug; 38(3):341-350. PubMed ID: 30007455 [TBL] [Abstract][Full Text] [Related]
11. Evolution of urticaria pigmentosa into indolent systemic mastocytosis: abnormal immunophenotype of mast cells without evidence of c-kit mutation ASP-816-VAL. Noack F; Escribano L; Sotlar K; Nunez R; Schuetze K; Valent P; Horny HP Leuk Lymphoma; 2003 Feb; 44(2):313-9. PubMed ID: 12688351 [TBL] [Abstract][Full Text] [Related]
12. Clonal mast cell disorders in patients with systemic reactions to Hymenoptera stings and increased serum tryptase levels. Bonadonna P; Perbellini O; Passalacqua G; Caruso B; Colarossi S; Dal Fior D; Castellani L; Bonetto C; Frattini F; Dama A; Martinelli G; Chilosi M; Senna G; Pizzolo G; Zanotti R J Allergy Clin Immunol; 2009 Mar; 123(3):680-6. PubMed ID: 19135713 [TBL] [Abstract][Full Text] [Related]
13. Urinary 11β-PGF2α and N-methyl histamine correlate with bone marrow biopsy findings in mast cell disorders. Divekar R; Butterfield J Allergy; 2015 Oct; 70(10):1230-8. PubMed ID: 26095439 [TBL] [Abstract][Full Text] [Related]
14. Anaphylaxis with clonal mast cells in normal looking skin - a new entity? Bretterklieber A; Beham-Schmid C; Sturm GJ; Berghold A; Brezinschek R; Aberer W; Aberer E Allergy; 2015 Jul; 70(7):864-72. PubMed ID: 25899109 [TBL] [Abstract][Full Text] [Related]
16. Expanding spectrum of mast cell activation disorders: monoclonal and idiopathic mast cell activation syndromes. Picard M; Giavina-Bianchi P; Mezzano V; Castells M Clin Ther; 2013 May; 35(5):548-62. PubMed ID: 23642289 [TBL] [Abstract][Full Text] [Related]
17. [Tryptase: A practical guide for the physician]. Lobbes H; Reynaud Q; Mainbourg S; Lega JC; Durieu I; Durupt S Rev Med Interne; 2020 Nov; 41(11):748-755. PubMed ID: 32712042 [TBL] [Abstract][Full Text] [Related]
18. A distinct biomolecular profile identifies monoclonal mast cell disorders in patients with idiopathic anaphylaxis. Carter MC; Desai A; Komarow HD; Bai Y; Clayton ST; Clark AS; Ruiz-Esteves KN; Long LM; Cantave D; Wilson TM; Scott LM; Simakova O; Jung MY; Hahn J; Maric I; Metcalfe DD J Allergy Clin Immunol; 2018 Jan; 141(1):180-188.e3. PubMed ID: 28629749 [TBL] [Abstract][Full Text] [Related]
19. Somatic c-KIT activating mutation in urticaria pigmentosa and aggressive mastocytosis: establishment of clonality in a human mast cell neoplasm. Longley BJ; Tyrrell L; Lu SZ; Ma YS; Langley K; Ding TG; Duffy T; Jacobs P; Tang LH; Modlin I Nat Genet; 1996 Mar; 12(3):312-4. PubMed ID: 8589724 [TBL] [Abstract][Full Text] [Related]
20. The transcriptome of the human mast cell leukemia cells HMC-1.2: an approach to identify specific changes in the gene expression profile in KitD816V systemic mastocytosis. Haenisch B; Herms S; Molderings GJ Immunol Res; 2013 May; 56(1):155-62. PubMed ID: 23504229 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]